• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开始血液透析且从未服用过钙剂、骨化三醇或维生素 D 类似物的患者中,血清甲状旁腺激素水平与腹主动脉钙化的关系。

Relationship between serum parathyroid hormone levels and abdominal aortic calcification in patients starting hemodialysis who have never taken calcium tablets, calcitriol, or vitamin D analogs.

机构信息

Division of Nephrology and Endocrinology, The Chonggang General Hospital Affiliated to Chongqing University of Posts and Telecommunications, Chongqing, People's Republic of China.

Department of Emergency and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

出版信息

Ren Fail. 2022 Dec;44(1):1409-1416. doi: 10.1080/0886022X.2022.2114369.

DOI:10.1080/0886022X.2022.2114369
PMID:36000910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9415453/
Abstract

BACKGROUND

Vascular calcification (VC) and secondary hyperparathyroidism (SHPT) are important causes of the high incidence of cardiovascular events in chronic kidney disease (CKD) patients. The relationship between parathyroid hormone (PTH) and VC is very complex. The aim of this study was to determine the correlation between PTH levels and abdominal aortic calcification (AAC) in patients starting hemodialysis who had not received calcium tablets, calcium-containing phosphorus binders, calcitriol, or vitamin D analogs.

METHODS

Seventy-one patients were included. Latero-lateral X-ray lumbar radiography, serum intact PTH (iPTH) levels, and predialysis biochemical parameters were obtained. The degree of AAC was evaluated according to the methods described previously by Kauppila et al.

RESULTS

We found that there was a strong negative correlation between serum PTH and AAC (Spearman's rho -0.76,  < 0.001). Receiver operating characteristic (ROC) curve analysis showed that low serum PTH level could predict the presence and extent of AAC (area under the curve values were 0.9013 [ < 0.0001] and 0.780 [ = 0.0041], respectively).

CONCLUSIONS

Our results indicate that serum PTH level is significantly negatively correlated with AAC within a certain concentration range in patients starting hemodialysis who had not received calcium tablets, calcium-containing phosphorus binders, calcitriol, or vitamin D analogs.

摘要

背景

血管钙化(VC)和继发性甲状旁腺功能亢进症(SHPT)是慢性肾脏病(CKD)患者心血管事件高发的重要原因。甲状旁腺激素(PTH)与 VC 之间的关系非常复杂。本研究旨在确定未接受钙剂、含钙磷结合剂、骨化三醇或维生素 D 类似物治疗的开始血液透析患者的 PTH 水平与腹主动脉钙化(AAC)之间的相关性。

方法

共纳入 71 例患者。获取侧位腰椎 X 线片、血清全段甲状旁腺激素(iPTH)水平和透析前生化参数。根据 Kauppila 等人先前描述的方法评估 AAC 程度。

结果

我们发现血清 PTH 与 AAC 之间存在强烈的负相关关系(Spearman's rho -0.76,<0.001)。受试者工作特征(ROC)曲线分析显示,低血清 PTH 水平可预测 AAC 的存在和程度(曲线下面积值分别为 0.9013 [<0.0001] 和 0.780 [=0.0041])。

结论

我们的研究结果表明,在未接受钙剂、含钙磷结合剂、骨化三醇或维生素 D 类似物治疗的开始血液透析患者中,血清 PTH 水平在一定浓度范围内与 AAC 显著负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/9f9fe9025d15/IRNF_A_2114369_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/e94b5f971dc4/IRNF_A_2114369_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/c9f8660fcef5/IRNF_A_2114369_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/9f9fe9025d15/IRNF_A_2114369_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/e94b5f971dc4/IRNF_A_2114369_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/c9f8660fcef5/IRNF_A_2114369_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139a/9415453/9f9fe9025d15/IRNF_A_2114369_F0003_C.jpg

相似文献

1
Relationship between serum parathyroid hormone levels and abdominal aortic calcification in patients starting hemodialysis who have never taken calcium tablets, calcitriol, or vitamin D analogs.开始血液透析且从未服用过钙剂、骨化三醇或维生素 D 类似物的患者中,血清甲状旁腺激素水平与腹主动脉钙化的关系。
Ren Fail. 2022 Dec;44(1):1409-1416. doi: 10.1080/0886022X.2022.2114369.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
4
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.维持性透析患者血管钙化的进展及临床转归。
JAMA Netw Open. 2023 May 1;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909.
5
Control of parathyroid function in patients with a short history of hemodialysis.血液透析病史较短患者的甲状旁腺功能控制
Ther Apher Dial. 2005 Feb;9(1):39-43. doi: 10.1111/j.1774-9987.2005.00212.x.
6
Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.甲状旁腺功能作为血液透析患者对骨化三醇治疗反应的一个决定因素。
Kidney Int. 1999 Jul;56(1):306-17. doi: 10.1046/j.1523-1755.1999.00538.x.
7
Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.重复血液透析对接受维生素D(骨化三醇)治疗的尿毒症患者循环免疫反应性甲状旁腺激素水平的急性影响。
Nephron. 1991;57(3):273-82. doi: 10.1159/000186275.
8
Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.口服阿法骨化醇转化为骨化三醇用于治疗慢性血液透析患者的继发性甲状旁腺功能亢进
Int Urol Nephrol. 2017 Feb;49(2):325-328. doi: 10.1007/s11255-016-1446-1. Epub 2016 Nov 8.
9
Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.早期使用西那卡塞治疗血液透析患者继发性甲状旁腺功能亢进症:三年临床经验。
Artif Organs. 2011 Dec;35(12):1186-93. doi: 10.1111/j.1525-1594.2011.01270.x. Epub 2011 Aug 17.
10
Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?我们是否过度关注继发性甲状旁腺功能亢进,而低估了透析患者中更常见的继发性甲状旁腺功能减退?
J Assoc Physicians India. 2012 Feb;60:102-5.

引用本文的文献

1
Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study.维持性血液透析的终末期肾病中心血管疾病的病因:一项纵向和孟德尔随机化研究
Front Cardiovasc Med. 2024 Jul 18;11:1306159. doi: 10.3389/fcvm.2024.1306159. eCollection 2024.

本文引用的文献

1
Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.继发性甲状旁腺功能亢进和高磷血症对慢性肾脏病进展及心血管事件的独立影响:来自NEFRONA队列的分析
Nephrol Dial Transplant. 2022 Mar 25;37(4):663-672. doi: 10.1093/ndt/gfab184.
2
Abdominal aortic calcification is superior to other arteries calcification in predicting the mortality in peritoneal dialysis patients - a 8 years cohort study.腹主动脉钙化在预测腹膜透析患者死亡率方面优于其他动脉钙化 - 一项 8 年队列研究。
BMC Nephrol. 2019 Dec 2;20(1):439. doi: 10.1186/s12882-019-1593-6.
3
Calcification of abdominal aorta in patients recently starting hemodialysis: A single-center experience from Egypt.
近期开始血液透析的患者腹主动脉钙化:来自埃及的单中心经验。
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):819-824. doi: 10.4103/1319-2442.265457.
4
Association of abdominal aortic calcification estimated by plain radiography with outcomes in haemodialysis patients: A 6-year follow-up study.基于普通 X 射线的腹主动脉钙化评估与血液透析患者预后的相关性:一项 6 年随访研究。
Nephrology (Carlton). 2020 Jul;25(7):559-565. doi: 10.1111/nep.13644. Epub 2019 Aug 30.
5
Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients.营养不良、炎症、血管钙化进展和生存:血液透析患者的相互关系。
PLoS One. 2019 May 2;14(5):e0216415. doi: 10.1371/journal.pone.0216415. eCollection 2019.
6
Acute-phase proteins as promoters of abdominal aortic calcification in chronic dialysis patients.急性期蛋白作为慢性透析患者腹主动脉钙化的促进因素
Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):376-386. doi: 10.4103/1319-2442.256845.
7
Study on the Prevalence of Vascular Calcification in Different Types of Arteries and Influencing Factors in Maintenance Peritoneal Dialysis Patients.维持性腹膜透析患者不同类型动脉血管钙化的患病率及影响因素研究。
Blood Purif. 2019;47 Suppl 1(Suppl 1):8-16. doi: 10.1159/000496218. Epub 2019 Jan 30.
8
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.
9
Parathyroid Hormone Fragments: New Targets for the Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.甲状旁腺激素片段:慢性肾脏病-矿物质和骨异常诊断和治疗的新靶点。
Biomed Res Int. 2018 Nov 29;2018:9619253. doi: 10.1155/2018/9619253. eCollection 2018.
10
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study.接受透析的中国患者血管钙化的患病率和危险因素:一项前瞻性队列研究的基线结果。
Curr Med Res Opin. 2018 Aug;34(8):1491-1500. doi: 10.1080/03007995.2018.1467886. Epub 2018 May 3.